

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen processing and presentation (GO:0002579) | 7.48913644 |
| 2 | regulation of acrosome reaction (GO:0060046) | 6.94728954 |
| 3 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.94634418 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 6.18092566 |
| 5 | regulation of antigen processing and presentation (GO:0002577) | 5.82934480 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.49181454 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 4.92255246 |
| 8 | regulation of Cdc42 GTPase activity (GO:0043088) | 4.81282831 |
| 9 | plasma membrane fusion (GO:0045026) | 4.77219153 |
| 10 | macroautophagy (GO:0016236) | 4.56131362 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.33958582 |
| 12 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.87788978 |
| 13 | response to misfolded protein (GO:0051788) | 3.78318406 |
| 14 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.74264979 |
| 15 | ethanol metabolic process (GO:0006067) | 3.64914452 |
| 16 | primary alcohol catabolic process (GO:0034310) | 3.51817369 |
| 17 | GPI anchor biosynthetic process (GO:0006506) | 3.50664310 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.46641841 |
| 19 | negative regulation of endopeptidase activity (GO:0010951) | 3.46188331 |
| 20 | positive regulation of glomerulus development (GO:0090193) | 3.40841867 |
| 21 | ethanol oxidation (GO:0006069) | 3.40574763 |
| 22 | negative regulation of metanephros development (GO:0072217) | 3.35617355 |
| 23 | cellular sodium ion homeostasis (GO:0006883) | 3.33142981 |
| 24 | brown fat cell differentiation (GO:0050873) | 3.33010804 |
| 25 | valine metabolic process (GO:0006573) | 3.32095882 |
| 26 | positive regulation of response to oxidative stress (GO:1902884) | 3.32033569 |
| 27 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.32033569 |
| 28 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.31522072 |
| 29 | negative regulation of peptidase activity (GO:0010466) | 3.31214175 |
| 30 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.30778241 |
| 31 | negative regulation of endocytosis (GO:0045806) | 3.30253038 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.22756582 |
| 33 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.19406790 |
| 34 | GPI anchor metabolic process (GO:0006505) | 3.18128397 |
| 35 | tonic smooth muscle contraction (GO:0014820) | 3.17593342 |
| 36 | carnitine transmembrane transport (GO:1902603) | 3.12880780 |
| 37 | triglyceride catabolic process (GO:0019433) | 3.10782696 |
| 38 | response to nitrosative stress (GO:0051409) | 3.08191370 |
| 39 | positive regulation of receptor biosynthetic process (GO:0010870) | 3.06473836 |
| 40 | white fat cell differentiation (GO:0050872) | 3.02480108 |
| 41 | regulation of complement activation (GO:0030449) | 3.02227850 |
| 42 | carnitine transport (GO:0015879) | 2.98636184 |
| 43 | amino-acid betaine transport (GO:0015838) | 2.98636184 |
| 44 | respiratory burst (GO:0045730) | 2.97665026 |
| 45 | cytolysis (GO:0019835) | 2.92254960 |
| 46 | acylglycerol catabolic process (GO:0046464) | 2.89902398 |
| 47 | neutral lipid catabolic process (GO:0046461) | 2.89902398 |
| 48 | artery smooth muscle contraction (GO:0014824) | 2.87957961 |
| 49 | metanephric tubule development (GO:0072170) | 2.86835290 |
| 50 | metanephric nephron tubule development (GO:0072234) | 2.86835290 |
| 51 | regulation of protein activation cascade (GO:2000257) | 2.85172371 |
| 52 | negative regulation of lipase activity (GO:0060192) | 2.83119522 |
| 53 | C21-steroid hormone metabolic process (GO:0008207) | 2.72298120 |
| 54 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.68307669 |
| 55 | regulation of histone H3-K27 methylation (GO:0061085) | 2.66333356 |
| 56 | glycerolipid catabolic process (GO:0046503) | 2.62331992 |
| 57 | metanephric nephron epithelium development (GO:0072243) | 2.61232147 |
| 58 | L-serine metabolic process (GO:0006563) | 2.57972663 |
| 59 | phospholipid homeostasis (GO:0055091) | 2.57855690 |
| 60 | positive regulation of vesicle fusion (GO:0031340) | 2.57514318 |
| 61 | regulation of lipoprotein metabolic process (GO:0050746) | 2.55641712 |
| 62 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.55379581 |
| 63 | prostaglandin biosynthetic process (GO:0001516) | 2.54881457 |
| 64 | prostanoid biosynthetic process (GO:0046457) | 2.54881457 |
| 65 | cysteine metabolic process (GO:0006534) | 2.54308944 |
| 66 | adaptation of signaling pathway (GO:0023058) | 2.51202924 |
| 67 | regulation of receptor biosynthetic process (GO:0010869) | 2.50440424 |
| 68 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.49626473 |
| 69 | negative regulation of protein autophosphorylation (GO:0031953) | 2.47861877 |
| 70 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.46973757 |
| 71 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.46725905 |
| 72 | positive regulation of sterol transport (GO:0032373) | 2.46059406 |
| 73 | positive regulation of cholesterol transport (GO:0032376) | 2.46059406 |
| 74 | sodium ion homeostasis (GO:0055078) | 2.44072045 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 2.43730389 |
| 76 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.41013988 |
| 77 | regulation of bile acid biosynthetic process (GO:0070857) | 2.40327733 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 2.38633625 |
| 79 | mannose metabolic process (GO:0006013) | 2.38611272 |
| 80 | prostanoid metabolic process (GO:0006692) | 2.37633265 |
| 81 | prostaglandin metabolic process (GO:0006693) | 2.37633265 |
| 82 | nephron tubule development (GO:0072080) | 2.37591567 |
| 83 | positive regulation of digestive system process (GO:0060456) | 2.37161385 |
| 84 | negative regulation of proteolysis (GO:0045861) | 2.36629715 |
| 85 | quaternary ammonium group transport (GO:0015697) | 2.33629154 |
| 86 | xenobiotic catabolic process (GO:0042178) | 2.31146673 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 2.30791365 |
| 88 | metanephric epithelium development (GO:0072207) | 2.30646818 |
| 89 | cell differentiation involved in metanephros development (GO:0072202) | 2.30624715 |
| 90 | negative regulation of kidney development (GO:0090185) | 2.29209488 |
| 91 | fatty acid beta-oxidation (GO:0006635) | 2.28481703 |
| 92 | negative regulation of protein processing (GO:0010955) | 2.27917709 |
| 93 | negative regulation of protein maturation (GO:1903318) | 2.27917709 |
| 94 | triglyceride biosynthetic process (GO:0019432) | 2.27785329 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 16.9649524 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 16.9649524 |
| 97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 16.0995029 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 15.2605314 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 14.0670367 |
| 100 | regulation of clathrin-mediated endocytosis (GO:2000369) | 10.4187899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 9.79736626 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.28350083 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78623252 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.88436531 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.04854713 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.92819654 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.87658046 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.27305692 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10114476 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98633397 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98364014 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97052111 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94652561 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65699854 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59844879 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55936331 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.50921784 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46220186 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40419137 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40169401 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35503847 |
| 22 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.33934269 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33824657 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33049794 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33049794 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30525279 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29979278 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25239474 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24011513 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19467091 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18559778 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18056118 |
| 33 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.17508693 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16948046 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16454628 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15919472 |
| 37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11089979 |
| 38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11055044 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10758148 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10635226 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08445472 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08413253 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06744362 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06258634 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05794266 |
| 46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05480231 |
| 47 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.05322625 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05313660 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05300356 |
| 50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03088081 |
| 51 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.02845438 |
| 52 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01298325 |
| 53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97622125 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97607874 |
| 55 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97290667 |
| 56 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96492408 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96481747 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96464139 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96464139 |
| 60 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.96013543 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95736235 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95437516 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95032566 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94923470 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94377542 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94293001 |
| 67 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93068094 |
| 68 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92365925 |
| 69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.92311787 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91740514 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90760794 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90436786 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88870363 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87226845 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86567433 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.86491342 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86051103 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85099718 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84119499 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83582525 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 0.83411488 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82794331 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82745749 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82267044 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81785474 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81785474 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81307199 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80906162 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80893757 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80508614 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79075325 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78806211 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77716071 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76962365 |
| 95 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76817584 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.76159861 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74884803 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74250205 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73971941 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73782144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.09015269 |
| 2 | MP0004381_abnormal_hair_follicle | 4.61462638 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.01569555 |
| 4 | MP0005670_abnormal_white_adipose | 3.14655078 |
| 5 | MP0002796_impaired_skin_barrier | 2.88085262 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.74292445 |
| 7 | MP0003136_yellow_coat_color | 2.67163488 |
| 8 | MP0005666_abnormal_adipose_tissue | 2.46564627 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.29412803 |
| 10 | MP0002163_abnormal_gland_morphology | 2.28135672 |
| 11 | MP0004130_abnormal_muscle_cell | 2.23528285 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.14846170 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.14585024 |
| 14 | MP0008004_abnormal_stomach_pH | 2.11926374 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.09756468 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.07467605 |
| 17 | MP0002254_reproductive_system_inflammat | 1.97085843 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.92907145 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.90948077 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.89257859 |
| 21 | MP0000003_abnormal_adipose_tissue | 1.88351672 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.87532440 |
| 23 | MP0005187_abnormal_penis_morphology | 1.86217595 |
| 24 | MP0005360_urolithiasis | 1.84643531 |
| 25 | MP0003195_calcinosis | 1.74092875 |
| 26 | MP0001727_abnormal_embryo_implantation | 1.72285929 |
| 27 | MP0005365_abnormal_bile_salt | 1.71714782 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.63133352 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.62823139 |
| 30 | MP0001851_eye_inflammation | 1.56342469 |
| 31 | MP0000383_abnormal_hair_follicle | 1.50906201 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.48385496 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.46844282 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.44610469 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.43573955 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.38723899 |
| 37 | MP0000467_abnormal_esophagus_morphology | 1.34214190 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.33120557 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.32955680 |
| 40 | MP0000427_abnormal_hair_cycle | 1.26765189 |
| 41 | MP0004858_abnormal_nervous_system | 1.26087424 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.23172864 |
| 43 | MP0000751_myopathy | 1.22812787 |
| 44 | MP0002249_abnormal_larynx_morphology | 1.22507626 |
| 45 | MP0005501_abnormal_skin_physiology | 1.19569651 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.19047585 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.16846547 |
| 48 | MP0003690_abnormal_glial_cell | 1.14131641 |
| 49 | MP0003252_abnormal_bile_duct | 1.11998866 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11607272 |
| 51 | MP0009763_increased_sensitivity_to | 1.11391434 |
| 52 | MP0005275_abnormal_skin_tensile | 1.10544919 |
| 53 | MP0004272_abnormal_basement_membrane | 1.10483079 |
| 54 | MP0010771_integument_phenotype | 1.05917093 |
| 55 | MP0000609_abnormal_liver_physiology | 1.05763311 |
| 56 | MP0002971_abnormal_brown_adipose | 1.04741656 |
| 57 | MP0003011_delayed_dark_adaptation | 1.03642201 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.00636560 |
| 59 | MP0009643_abnormal_urine_homeostasis | 0.99918284 |
| 60 | MP0001216_abnormal_epidermal_layer | 0.99722380 |
| 61 | MP0002090_abnormal_vision | 0.97468386 |
| 62 | MP0002282_abnormal_trachea_morphology | 0.97055189 |
| 63 | MP0002909_abnormal_adrenal_gland | 0.96777807 |
| 64 | MP0002060_abnormal_skin_morphology | 0.96249665 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 0.93537321 |
| 66 | MP0008872_abnormal_physiological_respon | 0.93290988 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.92952864 |
| 68 | MP0003075_altered_response_to | 0.92894930 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.89558482 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 0.87817555 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.86951870 |
| 72 | MP0003938_abnormal_ear_development | 0.86109566 |
| 73 | MP0004270_analgesia | 0.85975024 |
| 74 | MP0000750_abnormal_muscle_regeneration | 0.85512029 |
| 75 | MP0005451_abnormal_body_composition | 0.83690812 |
| 76 | MP0002098_abnormal_vibrissa_morphology | 0.83396597 |
| 77 | MP0004947_skin_inflammation | 0.83333793 |
| 78 | MP0002168_other_aberrant_phenotype | 0.81883319 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.80928327 |
| 80 | MP0001177_atelectasis | 0.80600379 |
| 81 | MP0000537_abnormal_urethra_morphology | 0.79912834 |
| 82 | MP0005408_hypopigmentation | 0.79312209 |
| 83 | MP0006138_congestive_heart_failure | 0.78794908 |
| 84 | MP0008995_early_reproductive_senescence | 0.78665044 |
| 85 | MP0005164_abnormal_response_to | 0.78029959 |
| 86 | MP0005334_abnormal_fat_pad | 0.77440538 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.77085924 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74721997 |
| 89 | MP0005332_abnormal_amino_acid | 0.74622421 |
| 90 | MP0001486_abnormal_startle_reflex | 0.73494476 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.72799693 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.72049752 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.69471217 |
| 94 | MP0000566_synostosis | 0.69119802 |
| 95 | MP0002970_abnormal_white_adipose | 0.69102836 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.68922694 |
| 97 | MP0003123_paternal_imprinting | 0.66872078 |
| 98 | MP0005535_abnormal_body_temperature | 0.66856802 |
| 99 | MP0008874_decreased_physiological_sensi | 0.64866968 |
| 100 | MP0009115_abnormal_fat_cell | 0.63755602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Choroideremia (HP:0001139) | 8.25299634 |
| 2 | Abnormality of the fovea (HP:0000493) | 7.89354677 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.62664670 |
| 4 | Complement deficiency (HP:0004431) | 6.12439819 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.91537525 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.59188258 |
| 7 | 11 pairs of ribs (HP:0000878) | 4.98241859 |
| 8 | Hypopigmentation of the fundus (HP:0007894) | 4.72823929 |
| 9 | Hand muscle atrophy (HP:0009130) | 4.40438482 |
| 10 | Abnormality of complement system (HP:0005339) | 4.38710451 |
| 11 | Action tremor (HP:0002345) | 4.31351283 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96018735 |
| 13 | Stridor (HP:0010307) | 3.87383478 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.70873810 |
| 15 | Upper limb amyotrophy (HP:0009129) | 3.64489450 |
| 16 | Distal upper limb amyotrophy (HP:0007149) | 3.64489450 |
| 17 | Diaphragmatic weakness (HP:0009113) | 3.55968009 |
| 18 | Potter facies (HP:0002009) | 3.51335466 |
| 19 | Facial shape deformation (HP:0011334) | 3.51335466 |
| 20 | Facial diplegia (HP:0001349) | 3.49237350 |
| 21 | Missing ribs (HP:0000921) | 3.49224398 |
| 22 | Metaphyseal cupping (HP:0003021) | 3.48347500 |
| 23 | Clumsiness (HP:0002312) | 3.46020230 |
| 24 | Premature skin wrinkling (HP:0100678) | 3.34342253 |
| 25 | Intention tremor (HP:0002080) | 3.29670846 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 3.29073362 |
| 27 | Abnormal hemoglobin (HP:0011902) | 3.27284349 |
| 28 | Reticulocytopenia (HP:0001896) | 3.19720691 |
| 29 | Hyperglycinuria (HP:0003108) | 3.16105779 |
| 30 | Hyperphosphatemia (HP:0002905) | 2.97539246 |
| 31 | Nonprogressive disorder (HP:0003680) | 2.90994690 |
| 32 | Hyperglycinemia (HP:0002154) | 2.90802839 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.87708541 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87708541 |
| 35 | Myocardial infarction (HP:0001658) | 2.87334071 |
| 36 | Vascular calcification (HP:0004934) | 2.84116626 |
| 37 | Abnormality of the calcaneus (HP:0008364) | 2.75832174 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.65538222 |
| 39 | Hemiplegia (HP:0002301) | 2.59414140 |
| 40 | Abnormality of the musculature of the hand (HP:0001421) | 2.57787330 |
| 41 | Ankle clonus (HP:0011448) | 2.55803297 |
| 42 | Myopathic facies (HP:0002058) | 2.50778682 |
| 43 | Agitation (HP:0000713) | 2.50420775 |
| 44 | Infantile muscular hypotonia (HP:0008947) | 2.48994098 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.46578881 |
| 46 | Anhidrosis (HP:0000970) | 2.42060509 |
| 47 | Cortical dysplasia (HP:0002539) | 2.40041261 |
| 48 | Oligomenorrhea (HP:0000876) | 2.36707880 |
| 49 | Hypoventilation (HP:0002791) | 2.30535476 |
| 50 | Acanthosis nigricans (HP:0000956) | 2.26832606 |
| 51 | Tubulointerstitial fibrosis (HP:0005576) | 2.22981659 |
| 52 | Concave nail (HP:0001598) | 2.19373127 |
| 53 | Skin nodule (HP:0200036) | 2.17986010 |
| 54 | Abnormality of the vocal cords (HP:0008777) | 2.16343843 |
| 55 | Hypophosphatemic rickets (HP:0004912) | 2.16264456 |
| 56 | Spondylolisthesis (HP:0003302) | 2.16020343 |
| 57 | Abnormality of macular pigmentation (HP:0008002) | 2.14456655 |
| 58 | Mutism (HP:0002300) | 2.08341001 |
| 59 | Parakeratosis (HP:0001036) | 2.07188867 |
| 60 | Hypertriglyceridemia (HP:0002155) | 2.02539379 |
| 61 | Hypotrichosis (HP:0001006) | 2.02250043 |
| 62 | Deep venous thrombosis (HP:0002625) | 1.93764440 |
| 63 | Restlessness (HP:0000711) | 1.90205990 |
| 64 | Thin ribs (HP:0000883) | 1.88929595 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 1.88165613 |
| 66 | Duplicated collecting system (HP:0000081) | 1.85368681 |
| 67 | Pseudobulbar signs (HP:0002200) | 1.85332468 |
| 68 | Ketoacidosis (HP:0001993) | 1.84714012 |
| 69 | Abnormality of the dental root (HP:0006486) | 1.83770195 |
| 70 | Taurodontia (HP:0000679) | 1.83770195 |
| 71 | Abnormality of permanent molar morphology (HP:0011071) | 1.83770195 |
| 72 | Subcapsular cataract (HP:0000523) | 1.81716096 |
| 73 | Central scotoma (HP:0000603) | 1.80670482 |
| 74 | Focal segmental glomerulosclerosis (HP:0000097) | 1.78014085 |
| 75 | Depressed nasal ridge (HP:0000457) | 1.77431253 |
| 76 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75527083 |
| 77 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75527083 |
| 78 | Aplasia involving bones of the extremities (HP:0009825) | 1.75527083 |
| 79 | Soft skin (HP:0000977) | 1.75219582 |
| 80 | Ectopia lentis (HP:0001083) | 1.75083408 |
| 81 | Abnormality of molar morphology (HP:0011070) | 1.74236662 |
| 82 | Abnormality of molar (HP:0011077) | 1.74236662 |
| 83 | Hypoplastic nipples (HP:0002557) | 1.72971065 |
| 84 | Oligodontia (HP:0000677) | 1.72778436 |
| 85 | Abnormality of the lumbar spine (HP:0100712) | 1.71624578 |
| 86 | Xanthomatosis (HP:0000991) | 1.70906988 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70600002 |
| 88 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.70591126 |
| 89 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.70591126 |
| 90 | Myokymia (HP:0002411) | 1.69816152 |
| 91 | Glomerulosclerosis (HP:0000096) | 1.69391381 |
| 92 | Growth hormone excess (HP:0000845) | 1.66987314 |
| 93 | Lip pit (HP:0100267) | 1.66609287 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 1.62932911 |
| 95 | Tongue fasciculations (HP:0001308) | 1.58632341 |
| 96 | Abnormality of the 4th metacarpal (HP:0010012) | 1.57614511 |
| 97 | Hemorrhage of the eye (HP:0011885) | 1.57114539 |
| 98 | Muscle fibrillation (HP:0010546) | 1.56528341 |
| 99 | Cervical subluxation (HP:0003308) | 1.55799501 |
| 100 | Hypoplasia of the uterus (HP:0000013) | 1.54849696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 3.55589401 |
| 2 | EEF2K | 3.51739806 |
| 3 | MAP3K12 | 3.21969185 |
| 4 | TAOK3 | 3.06426226 |
| 5 | LATS1 | 2.80182076 |
| 6 | MAP2K4 | 2.78977039 |
| 7 | MAP3K4 | 2.45810676 |
| 8 | SIK1 | 2.36940701 |
| 9 | TRIB3 | 2.32927574 |
| 10 | LATS2 | 2.14220984 |
| 11 | LRRK2 | 2.12535458 |
| 12 | MAP3K13 | 2.12126930 |
| 13 | MAPKAPK5 | 2.05233819 |
| 14 | FER | 2.04558619 |
| 15 | MAPKAPK3 | 1.98937290 |
| 16 | MAP3K11 | 1.76501363 |
| 17 | LMTK2 | 1.74473142 |
| 18 | TRPM7 | 1.72888111 |
| 19 | RIPK4 | 1.64031933 |
| 20 | BMX | 1.63415343 |
| 21 | KSR2 | 1.60988005 |
| 22 | STK24 | 1.54069341 |
| 23 | RIPK1 | 1.52759108 |
| 24 | MAP3K6 | 1.45932731 |
| 25 | MST4 | 1.45103896 |
| 26 | PKN2 | 1.34712120 |
| 27 | PIK3CA | 1.30699096 |
| 28 | ERBB3 | 1.23963168 |
| 29 | TTN | 1.20323691 |
| 30 | EPHB1 | 1.16263488 |
| 31 | MARK2 | 1.16224925 |
| 32 | PAK3 | 1.15396692 |
| 33 | MST1R | 1.14266350 |
| 34 | YES1 | 1.13497394 |
| 35 | NTRK3 | 1.13286404 |
| 36 | MYLK | 1.12975202 |
| 37 | PAK6 | 1.11195970 |
| 38 | ILK | 1.08920060 |
| 39 | WNK1 | 1.08302681 |
| 40 | ERN1 | 1.08023738 |
| 41 | RET | 1.07244368 |
| 42 | NTRK2 | 1.03840318 |
| 43 | BCKDK | 1.03342058 |
| 44 | IRAK2 | 1.01376692 |
| 45 | MAP3K9 | 0.99227633 |
| 46 | PTK2 | 0.97658861 |
| 47 | ERBB4 | 0.97265732 |
| 48 | TTK | 0.97157712 |
| 49 | INSRR | 0.97134550 |
| 50 | MET | 0.97079430 |
| 51 | STK38L | 0.94203902 |
| 52 | NTRK1 | 0.86081587 |
| 53 | RPS6KB2 | 0.84745154 |
| 54 | PRKD3 | 0.83783585 |
| 55 | MAP3K7 | 0.80957182 |
| 56 | EPHB2 | 0.79717245 |
| 57 | MAP3K1 | 0.76239712 |
| 58 | MAP2K7 | 0.74049587 |
| 59 | STK38 | 0.73863958 |
| 60 | PAK2 | 0.70125007 |
| 61 | TYK2 | 0.68949143 |
| 62 | CAMK1D | 0.67643736 |
| 63 | MAPK12 | 0.65995336 |
| 64 | TIE1 | 0.65588925 |
| 65 | EGFR | 0.64987025 |
| 66 | DDR2 | 0.64574646 |
| 67 | MOS | 0.63993146 |
| 68 | STK10 | 0.63863320 |
| 69 | WNK3 | 0.63776293 |
| 70 | PRKCH | 0.62984068 |
| 71 | CAMK1G | 0.62068572 |
| 72 | CSK | 0.60568102 |
| 73 | BMPR2 | 0.60162149 |
| 74 | JAK2 | 0.59185214 |
| 75 | PDPK1 | 0.56009702 |
| 76 | PDK1 | 0.54011908 |
| 77 | PDK3 | 0.52612061 |
| 78 | PDK4 | 0.52612061 |
| 79 | MAPK4 | 0.52441433 |
| 80 | STK3 | 0.51511804 |
| 81 | PDK2 | 0.50026208 |
| 82 | PDGFRA | 0.49296504 |
| 83 | SRC | 0.49172719 |
| 84 | FRK | 0.42822251 |
| 85 | SGK1 | 0.42091249 |
| 86 | ERBB2 | 0.42070547 |
| 87 | MAPK13 | 0.41974874 |
| 88 | UHMK1 | 0.40877677 |
| 89 | INSR | 0.40406949 |
| 90 | PTK6 | 0.40389738 |
| 91 | MAPK11 | 0.39460887 |
| 92 | FYN | 0.37584785 |
| 93 | FGFR2 | 0.36921155 |
| 94 | ABL2 | 0.36820734 |
| 95 | ROCK1 | 0.33267403 |
| 96 | IGF1R | 0.33018560 |
| 97 | PHKG1 | 0.31724502 |
| 98 | PHKG2 | 0.31724502 |
| 99 | PTK2B | 0.30368408 |
| 100 | PRKCZ | 0.29905245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.75666152 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99739550 |
| 3 | ABC transporters_Homo sapiens_hsa02010 | 2.81050793 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.78856702 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.74689511 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.68991735 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56581567 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.43103412 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.38219858 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.34802224 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.28711852 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26013000 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.23709677 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.18803163 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03825635 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03266932 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95895794 |
| 18 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.94432824 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89392500 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.78346354 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74861069 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71202119 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.59077279 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53204086 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52906616 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48146505 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37902270 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.35798183 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.24933240 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24112984 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16904844 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14895604 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08644808 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04186409 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98540702 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 0.91084651 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90558596 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90103700 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89216975 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86781271 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85381023 |
| 42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82213732 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82075587 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81139189 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81012066 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76341910 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74216805 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71641653 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.70897319 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65450673 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65171004 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63831748 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61988252 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61582587 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61451200 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60727944 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59017880 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57314474 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56970935 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.56369385 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56080713 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55717908 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.54784697 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54177438 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52919635 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.52245951 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51774095 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50014635 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49382809 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49031371 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47887122 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46905228 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44463333 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44370547 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43135868 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41208438 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40804403 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40275352 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39330470 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39163438 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38525542 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38018875 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37917029 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33686816 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32287817 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32128387 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31319241 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.30945109 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28231478 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.27118013 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26305205 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26209002 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24802802 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24559708 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23620032 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.23211064 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.22710024 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22594439 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.22081886 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22016361 |

